1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Neuroprotective Agents: new trials by email Literature Review of Neuroprotective Agents trials Research Report on Neuroprotective Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer Ganglioside-Monosialic Acid, 250ml normal saline (NS) - Chemotherapy-Related Cognitive Impairment, Breast Cancer | Phase 3 | Terminated | Sun Yat-sen University | 76 | 2022-02-08 | 2024-08-01 |
Breast Neoplasms (1) · Chemotherapy-Related Cognitive Impairment (1)
China (1)